tradingkey.logo

Aquestive Therapeutics Announces FDA Issuance Of Complete Response Letter For Anaphylm

ReutersFeb 2, 2026 12:35 PM

- Aquestive Therapeutics Inc AQST.O:

  • AQUESTIVE THERAPEUTICS ANNOUNCES FDA ISSUANCE OF COMPLETE RESPONSE LETTER FOR ANAPHYLM™

  • AQUESTIVE THERAPEUTICS INC - DEFICIENCIES LIMITED TO PACKAGING AND ADMINISTRATION

  • AQUESTIVE THERAPEUTICS INC - COMPANY EXPECTS TO RESUBMIT AS EARLY AS Q3 2026

  • AQUESTIVE THERAPEUTICS INC - PLANS TO SUBMIT IN CANADA AND EU BY END OF 2026

  • AQUESTIVE THERAPEUTICS INC: PLANS TO REQUEST RAPID REVIEW BY FDA

  • AQUESTIVE THERAPEUTICS INC - COMPANY ANTICIPATES ENDING 2026 WITH SIGNIFICANT CASH

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI